Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers

rDEN4Δ30-4995 is a live attenuated dengue virus type 4 (DENV4) vaccine candidate specifically designed as a further attenuated derivative of the rDEN4Δ30 parent virus. In a previous study, 5 of 20 vaccinees who received 10(5) plaque-forming units (PFU) of rDEN4Δ30 developed a transient elevation of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wright, Peter F., Durbin, Anna P., Whitehead, Stephen S., Ikizler, Mine R., Henderson, Susan, Blaney, Joseph E., Thumar, Bhavin, Ankrah, Sharon, Rock, Michael T., McKinney, Brett A., Murphy, Brian R., Schmidt, Alexander C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2829759/
https://ncbi.nlm.nih.gov/pubmed/19861619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2009.09-0131
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge